Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer.
Dijkgraaf EM, Santegoets SJ, Reyners AK, Goedemans R, Wouters MC, Kenter GG, van Erkel AR, van Poelgeest MI, Nijman HW, van der Hoeven JJ, Welters MJ, van der Burg SH, Kroep JR. Dijkgraaf EM, et al. Among authors: van erkel ar, van der burg sh, van der hoeven jj, van poelgeest mi. Ann Oncol. 2015 Oct;26(10):2141-9. doi: 10.1093/annonc/mdv309. Epub 2015 Jul 27. Ann Oncol. 2015. PMID: 26216383 Free article. Clinical Trial.
A phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer.
Dijkgraaf EM, Santegoets SJ, Reyners AK, Goedemans R, Nijman HW, van Poelgeest MI, van Erkel AR, Smit VT, Daemen TA, van der Hoeven JJ, Melief CJ, Welters MJ, Kroep JR, van der Burg SH. Dijkgraaf EM, et al. Among authors: van erkel ar, van der burg sh, van der hoeven jj, van poelgeest mi. Oncotarget. 2015 Oct 13;6(31):32228-43. doi: 10.18632/oncotarget.4772. Oncotarget. 2015. PMID: 26334096 Free PMC article. Clinical Trial.
Correction to: Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases.
Tong TML, Fiocco M, van Duijn-de Vreugd JJ, Lutjeboer J, Speetjens FM, Tijl FGJ, Sitsen ME, Zoethout RWM, Martini CH, Vahrmeijer AL, van der Meer RW, van Rijswijk CSP, van Erkel AR, Kapiteijn E, Burgmans MC. Tong TML, et al. Among authors: van erkel ar. Cardiovasc Intervent Radiol. 2024 May 6. doi: 10.1007/s00270-024-03733-w. Online ahead of print. Cardiovasc Intervent Radiol. 2024. PMID: 38709262 No abstract available.
Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases.
Tong TML, Fiocco M, van Duijn-de Vreugd JJ, Lutjeboer J, Speetjens FM, Tijl FGJ, Sitsen ME, Zoethout RWM, Martini CH, Vahrmeijer AL, van der Meer RW, van Rijswijk CSP, van Erkel AR, Kapiteijn E, Burgmans MC. Tong TML, et al. Among authors: van erkel ar. Cardiovasc Intervent Radiol. 2024 Apr 8. doi: 10.1007/s00270-024-03713-0. Online ahead of print. Cardiovasc Intervent Radiol. 2024. PMID: 38587534
Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial).
Hendriks P, Rietbergen DDD, van Erkel AR, Coenraad MJ, Arntz MJ, Bennink RJ, Braat AE, Crobach S, van Delden OM, Dibbets-Schneider P, van der Hulle T, Klümpen HJ, van der Meer RW, Nijsen JFW, van Rijswijk CSP, Roosen J, Ruijter BN, Smit F, Stam MK, Takkenberg RB, Tushuizen ME, van Velden FHP, de Geus-Oei LF, Burgmans MC; Dutch Hepatocellular and Cholangiocarcinoma Group. Hendriks P, et al. Among authors: van erkel ar. Eur J Nucl Med Mol Imaging. 2024 Jun;51(7):2085-2097. doi: 10.1007/s00259-024-06630-z. Epub 2024 Feb 8. Eur J Nucl Med Mol Imaging. 2024. PMID: 38329507 Free PMC article. Clinical Trial.
MRI in addition to CT in patients scheduled for local therapy of colorectal liver metastases (CAMINO): an international, multicentre, prospective, diagnostic accuracy trial.
Görgec B, Hansen IS, Kemmerich G, Syversveen T, Abu Hilal M, Belt EJT, Bosscha K, Burgmans MC, Cappendijk VC, D'Hondt M, Edwin B, van Erkel AR, Gielkens HAJ, Grünhagen DJ, Gobardhan PD, Hartgrink HH, Horsthuis K, Klompenhouwer EG, Kok NFM, Kint PAM, Kuhlmann K, Leclercq WKG, Lips DJ, Lutin B, Maas M, Marsman HA, Meijerink M, Meyer Y, Morone M, Peringa J, Sijberden JP, van Delden OM, van den Bergh JE, Vanhooymissen IJS, Vermaas M, Willemssen FEJA, Dijkgraaf MGW, Bossuyt PM, Swijnenburg RJ, Fretland ÅA, Verhoef C, Besselink MG, Stoker J; CAMINO Study Group. Görgec B, et al. Among authors: van erkel ar. Lancet Oncol. 2024 Jan;25(1):137-146. doi: 10.1016/S1470-2045(23)00572-7. Epub 2023 Dec 8. Lancet Oncol. 2024. PMID: 38081200
Intraprocedural assessment of ablation margins using computed tomography co-registration in hepatocellular carcinoma treatment with percutaneous ablation: IAMCOMPLETE study.
Hendriks P, van Dijk KM, Boekestijn B, Broersen A, van Duijn-de Vreugd JJ, Coenraad MJ, Tushuizen ME, van Erkel AR, van der Meer RW, van Rijswijk CS, Dijkstra J, de Geus-Oei LF, Burgmans MC. Hendriks P, et al. Among authors: van erkel ar. Diagn Interv Imaging. 2024 Feb;105(2):57-64. doi: 10.1016/j.diii.2023.07.002. Epub 2023 Jul 28. Diagn Interv Imaging. 2024. PMID: 37517969 Free article.
Combining Melphalan Percutaneous Hepatic Perfusion with Ipilimumab Plus Nivolumab in Advanced Uveal Melanoma: First Safety and Efficacy Data from the Phase Ib Part of the Chopin Trial.
Tong TML, Burgmans MC, Speetjens FM, van Erkel AR, van der Meer RW, van Rijswijk CSP, Jonker-Bos MA, Roozen CFM, Sporrel-Blokland M, Lutjeboer J, van Persijn van Meerten EL, Martini CH, Zoethout RWM, Tijl FGJ, Blank CU, Kapiteijn E. Tong TML, et al. Among authors: van erkel ar. Cardiovasc Intervent Radiol. 2023 Mar;46(3):350-359. doi: 10.1007/s00270-022-03338-1. Epub 2023 Jan 9. Cardiovasc Intervent Radiol. 2023. PMID: 36624292 Clinical Trial.
Value-assessment of computer-assisted navigation strategies during percutaneous needle placement.
Boekestijn I, Azargoshasb S, van Oosterom MN, Slof LJ, Dibbets-Schneider P, Dankelman J, van Erkel AR, Rietbergen DDD, van Leeuwen FWB. Boekestijn I, et al. Among authors: van erkel ar. Int J Comput Assist Radiol Surg. 2022 Oct;17(10):1775-1785. doi: 10.1007/s11548-022-02719-8. Epub 2022 Aug 7. Int J Comput Assist Radiol Surg. 2022. PMID: 35934773 Free PMC article.
Study Protocol: Adjuvant Holmium-166 Radioembolization After Radiofrequency Ablation in Early-Stage Hepatocellular Carcinoma Patients-A Dose-Finding Study (HORA EST HCC Trial).
Hendriks P, Rietbergen DDD, van Erkel AR, Coenraad MJ, Arntz MJ, Bennink RJ, Braat AE, Crobach ASLP, van Delden OM, van der Hulle T, Klümpen HJ, van der Meer RW, Nijsen JFW, van Rijswijk CSP, Roosen J, Ruijter BN, Smit F, Stam MK, Takkenberg RB, Tushuizen ME, van Velden FHP, de Geus-Oei LF, Burgmans MC; Dutch Hepatocellular Cholangiocarcinoma Group. Hendriks P, et al. Among authors: van erkel ar. Cardiovasc Intervent Radiol. 2022 Aug;45(8):1057-1063. doi: 10.1007/s00270-022-03162-7. Epub 2022 May 26. Cardiovasc Intervent Radiol. 2022. PMID: 35618860 Free PMC article. Clinical Trial.
72 results